Abiopharma

🔍 Doucet Terrence Gregory Joseph (Executive)

Company: Cronos Group Inc. (CRON)

Report Date: 2026-03-08

Detailed Transactions and Holdings:

• Acquired 24,434 shares of COMMON SHARES (Direct)
  Date: 2026-03-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 94,575.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 12,580 shares of COMMON SHARES at $3.51 per share (Direct)
  Date: 2026-03-08 | Code: F | equity_swap_involved: 0 | shares_owned_after: 81,995.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 24,434 shares of RESTRICTED STOCK UNITS (Derivative)
  Date: 2026-03-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 151,559.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Acquired 80,555 shares of RESTRICTED STOCK UNITS (Derivative)
  Date: 2026-03-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 232,114.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc.
• F2: The price reported is denominated in Canadian dollars.
• F3: On March 8, 2024, the Reporting Person was granted 73,308 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
• F4: On March 9, 2026, the Reporting Person was granted 80,555 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
• REMARKS: General Counsel and Corporate Secretary